UCB Anti-Epileptic Keppra To Be Launched With New Specialty Sales Force
Executive Summary
UCB Pharma will launch the anti-epileptic drug Keppra in the spring of 2000 with a new national specialty sales force, the company said following the Nov. 30 approval of the product.